UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000000879
Receipt number R000000598
Scientific Title Randomized controlled trial of efficacy and safety of pre-operative GnRH agonist administration for laparoscopic myomectomy.
Date of disclosure of the study information 2008/01/01
Last modified on 2009/03/06 18:15:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized controlled trial of efficacy and safety of pre-operative GnRH agonist administration for laparoscopic myomectomy.

Acronym

Effect of GnRHa for LM

Scientific Title

Randomized controlled trial of efficacy and safety of pre-operative GnRH agonist administration for laparoscopic myomectomy.

Scientific Title:Acronym

Effect of GnRHa for LM

Region

Japan


Condition

Condition

uterine fibroid

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The effects of pre-operative GnRHa therapy for laparoscopic myomectomy are evaluated by RCT.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The rate of myomas at 6 months after GnRHa administration.
The side effects during GnRHa administration.
The estimated bleeding during operation, duration of operation and the weight of extracted specimens.

Key secondary outcomes

The recurrence rate evaluated by MRI after LM.
Pregnancy outcome after LM.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification

YES

Dynamic allocation

YES

Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine Maneuver

Interventions/Control_1

leuprorelin acetate 1.88mg/month

Interventions/Control_2

no administration of GnRHa

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

45 years-old >=

Gender

Female

Key inclusion criteria

maximam diameter of largest fibroid present:>5cm but<=7cm
number of fibroids present that are greater than 5cm:<=3

Key exclusion criteria

Patients with a history of hypersensitivity to ingerdients of the investigational drug or to any synthetic LH-RH agent or LH-RH derivative
Women sho are or potentially may be pregnant
Lactating women
Women with non-diagnosable, abnormal bleedng of unknown origin

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroyuki Takeuchi ,MD

Organization

Juntendo univ. school of medicine

Division name

ob. & gy

Zip code


Address

Hongo 2-1-1 Bunkyo-ku Tokyo Japan

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name Iwaho Kikuchi ,MD

Organization

Juntendo univ. school of medicine

Division name

OB/GY

Zip code


Address

Hongo 2-1-1 Bunkyo-ku Tokyo Japan

TEL

03-3813-3111

Homepage URL


Email

kikuchi@med.juntendo.ac.jp


Sponsor or person

Institute

Dept. of OB/GY Juntendo univ. school of medicine

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2008 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2006 Year 10 Month 01 Day

Date of IRB


Anticipated trial start date

2006 Year 10 Month 01 Day

Last follow-up date

2009 Year 09 Month 01 Day

Date of closure to data entry

2009 Year 12 Month 01 Day

Date trial data considered complete

2010 Year 03 Month 01 Day

Date analysis concluded

2010 Year 06 Month 01 Day


Other

Other related information



Management information

Registered date

2007 Year 11 Month 05 Day

Last modified on

2009 Year 03 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000598


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name